a级黄色片免费播放_亚洲色最新高清av网站_午夜天堂AV免费在线观看_五月天婷亚洲天综合网手机

159-2642-3062 027-65317797
服務(wù)熱線（工作日：9:00-17:30）

瀏覽量: 99

  • 產(chǎn)品名稱： Research Grade Diridavumab
  • 產(chǎn)品貨號(hào)： CSV03801
  • 貨期： 現(xiàn)貨
  • 價(jià)格與訂購： 2480
  • 數(shù)量：
    庫存： 5
  • 規(guī)格： 100μg
  • 產(chǎn)品信息
  • 如何訂購
    Description
    Diridavumab, the alternative names CR6261, is a human monoclonal antibody direct against influenza A hemagglutinin. The CR6261 antibody was first discovered by the Scripps Institute and Crucell, a dutch biopharmaceutical company, and later developed by Janssen Pharmaceutical Companies of Johnson & Johnson under the trade name diridavumab. Cr6261 is under investigation in clinical trial NCT02016066 (A Study to Assess the Safety, Pharmacokinetics and Immunogenicity of Diridavumab in Japanese Healthy Participants).icon
    Catalog No.
    CSV03801
    Host species
    Humanized
    Species reactivity
    Human
    Form
    Liquid
    Storage buffer
    0.01M PBS, pH 7.4.
    Concentration
    1 mg/ml
    Purity
    >95% by SDS-PAGE.
    Clonality
    Monoclonal
    Isotype
    IgG1, lambda
    Applications
    Research Grade Diridavumab Biosimilar
    Target
    HA,Hemagglutinin
    Purification
    Protein A or G purified from cell culture supernatant.
    Endotoxin level
    Please contact with the lab for this information.
    Expression system
    Mammalian
    Accession
    P03455
    Stability and Storage
    Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
    Alternative Names
    CR-6261, CR6261, CAS: 1393659-46-5, Influenza Virus (Flu)
    Note
    For research use only .Not suitable for clinical or therapeutic use.